Skip to main content
Top
Published in: Clinical and Translational Oncology 12/2009

01-12-2009 | Special Article

Lung Cancer OncoGuia

Authors: P. Manchon Walsh, Rafael Aguiló, María Alejo, M. Mar Arnaiz, Julio Astudillo, Remei Blanco, Emili Canalís, Felip Cardenal, Víctor Curull, Enriqueta Felip, Rafael Fuentes, Ángel Gayete, Ana M. Giménez, Josep Jové, Carmen Lainez, Josep Lloreta, Ramón Marrades, José Ignacio Martínez, Xesca Martínez, M. Ángeles Montero, Cinta Pallarès, Ramón Palmero, Josep Ramírez, Nuria Rodríguez, Antoni Rosell, Josep Saumench, Nuria Viñolas, Ángel Olazábal, Lung Cancer OncoGuia Group

Published in: Clinical and Translational Oncology | Issue 12/2009

Login to get access
Metadata
Title
Lung Cancer OncoGuia
Authors
P. Manchon Walsh
Rafael Aguiló
María Alejo
M. Mar Arnaiz
Julio Astudillo
Remei Blanco
Emili Canalís
Felip Cardenal
Víctor Curull
Enriqueta Felip
Rafael Fuentes
Ángel Gayete
Ana M. Giménez
Josep Jové
Carmen Lainez
Josep Lloreta
Ramón Marrades
José Ignacio Martínez
Xesca Martínez
M. Ángeles Montero
Cinta Pallarès
Ramón Palmero
Josep Ramírez
Nuria Rodríguez
Antoni Rosell
Josep Saumench
Nuria Viñolas
Ángel Olazábal
Lung Cancer OncoGuia Group
Publication date
01-12-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 12/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0449-0

Other articles of this Issue 12/2009

Clinical and Translational Oncology 12/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine